What Is Nerandomilast (Jascayd)?
Nerandomilast (Jascayd) is a new oral medication used to treat adults with idiopathic pulmonary fibrosis (IPF). The U.S. Food and Drug Administration (FDA) approved nerandomilast in 2025. It’s the first…
Nerandomilast (Jascayd) is a new oral medication used to treat adults with idiopathic pulmonary fibrosis (IPF). The U.S. Food and Drug Administration (FDA) approved nerandomilast in 2025. It’s the first…